Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02554877 · ClinicalTrials.gov registry record · Phase 2
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A Phase 2 study of Type 2 Diabetes Mellitus, sponsored by Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 206
- Enrollment target
- 20
- Study locations
NCT02554877 is a Phase 2 study of Type 2 Diabetes Mellitus that has completed, run by Pfizer. The registered enrollment target is 206 participants, below the 2,747-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (93% lower). The trial reports 20 study locations across 9 states.
The verdict
NCT02554877, a Phase 2 study of Type 2 Diabetes Mellitus, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 206 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to determine whether PF-06291874 is effective in the treatment T2DM
Conditions Studied
Interventions
- DRUG Placebo
- DRUG PF-06291874
Study Locations (20)
California
- Anaheim Clinical Trials, LLC - Anaheim
- National Research Institute - Los Angeles
- NRC Research Institute - Orange
- Sierra Clinical Research - Roseville
- Encompass Clinical Research - Spring Valley
- Empire Clinical Research - Upland
- Diablo Clinical Research, Inc - Walnut Creek
Florida
- Clinical Research of South Florida - Coral Gables
- Avail Clinical Research, LLC - DeLand
- Suncoast Research Group, Llc - Miami
- QPS-MRA, LLC (Miami Research Associates) - South Miami
- Palm Beach Research Center - West Palm Beach
New Jersey
- Comprehensive Clinical Research - Berlin
- Clinilabs Inc. - Eatontown
Georgia
- WR-Mount Vernon Clinical Research, LLC - Sandy Springs
Hawaii
- East-West Medical Research Institute - Honolulu
Indiana
- Midwest Institute for Clinical Research - Indianapolis
Louisiana
- Crescent City Clinical Research Center, LLC - Metairie
Missouri
- St. Louis Clinical Trials, LC - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2015-10 |
| Est. Completion | 2016-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02554877
The ClinicalTrials.gov registry entry for NCT02554877 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 206 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,747-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (93% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type 2 Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02554877 reports 20 study locations spanning 9 distinct geographic areas - top geographies include California, Florida, New Jersey.
Frequently Asked Questions
What is clinical trial NCT02554877 about?
NCT02554877 is a clinical study titled "A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin". The purpose of this study is to determine whether PF-06291874 is effective in the treatment T2DM
What is the current status of trial NCT02554877?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 206 participants. The study started on 2015-10. Estimated completion is 2016-08.
What conditions does trial NCT02554877 study?
This clinical trial studies the following conditions: Type 2 Diabetes Mellitus.
What interventions are being tested in trial NCT02554877?
The interventions under investigation include: Placebo (DRUG), PF-06291874 (DRUG).
Who is sponsoring clinical trial NCT02554877?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02554877 being conducted?
This trial has 20 study locations across California, Florida, Georgia, Hawaii, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes
RECRUITING · Phase 2
-
Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
RECRUITING · Phase 2
-
Regulation of Endogenous Glucose Production by Central KATP Channels
RECRUITING · Phase 2
-
Signaling Mechanisms and Vascular Function in Patients With Diabetes Mellitus
COMPLETED · Phase 2
-
The Effect of Bariatric Surgery on Metabolism, the Metabolome and Microbiome in Patients With Type 2 Diabetes
COMPLETED · Phase 2
-
A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.